Reliferon 3MIU Injection is prescribed for the treatment of various conditions, including chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, multiple myeloma, follicular lymphoma, and hairy cell leukemia.
This medication is administered by a qualified medical professional via injection. It is crucial to continue the treatment for the duration advised by your doctor, as the length of therapy will vary depending on your specific needs and how you respond to the treatment. You must adhere precisely to your doctor’s instructions for administration; incorrect usage or taking an excessive dose can lead to severe side effects. While it may take several weeks or even months to observe or feel the benefits of this medicine, it is imperative not to discontinue its use unless specifically instructed by your doctor.
Common side effects associated with Reliferon 3MIU Injection include headache, dizziness, insomnia, vomiting, and nausea. A significant concern with this medicine is its potential to reduce the number of blood cells, which can increase your susceptibility to infections. Therefore, it is vital to inform your doctor immediately if you experience symptoms such as fever, chills, difficulty breathing, unusual bleeding or bruising, or dark-colored urine. Regular blood tests will be necessary to monitor your blood cell counts, as well as your thyroid, liver, kidney function, and serum electrolyte levels.
Before commencing treatment with Reliferon 3MIU Injection, disclose any pre-existing liver or kidney problems, or if you have a history of mental illness, to your doctor. It is especially important to report any past or current mental illness, mood changes, depression, vision changes, or suicidal thoughts, as this medicine can potentially exacerbate such conditions. Given that many other medications can interact with or be affected by Reliferon 3MIU Injection, ensure your healthcare team is aware of all the medications you are currently using. This medicine is not recommended during pregnancy or while breastfeeding. Effective contraception is crucial for both males and females throughout the treatment period to prevent pregnancy.
